drugset / Trial / NCT03573882
Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031
NaSingle-groupOpen-labelTreatment
Summary
Open Label Extension Study of Voxelotor Clinical Trial Participants with Sickle Cell Disease Who Participated in Voxelotor Clinical Trials
Timeline
- Start
- 2018-06-06
- Primary completion
- 2024-11-12
- Completion
- 2024-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voxelotor | Small molecule | 900 mg | Oral |
| Subject | Voxelotor | Small molecule | 1500 mg | Oral |